Luye Pharma's Rykindo (risperidone) Receives the US FDA’s Approval for the Treatment of Schizophrenia and Bipolar 1 Disorder
January 16, 2023
Luye Pharma Receives NMPA’s Approval of World First Boyoubei (biosimilar, denosumab) to Treat Postmenopausal Women with Osteoporos...
November 10, 2022
PharmaShots Weekly Snapshot (December 23-27, 2019)
December 30, 2019
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2023 PharmaShots - All Rights Reserved.